Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/11/21 → 3/10/25 |
Re: A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.
- Rupp, Richard (PI)
Project: Other project